|
|
 |
|
 |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
  |
|
 |
|
 |
|
 |
|
  |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
In this important, practical, and timely edition of AntiplateletWRAP, Dr Sunil Rao, an expert in the field of interventional cardiology and bleeding, discusses issues related to antiplatelet therapy with the thienopyridine, clopidogrel, focusing on the relationship between clopidogrel use and bleeding complications in the setting of CABG surgery.
Click to Learn More About This Program |
|
 |
|
 |
|
|
 |
|
In this "science-to-strategy" installment of ACS-WRAP®, Dr Harold L. Dauerman reviews the evolution of STEMI and acute coronary syndromes (ACS) therapy, and discusses the integration of bivalirudin into modern cardiovascular (CV) practice for patients with STEMI and high-risk ACS.
Click to Learn More About This Program
In this edition of STEMI-WRAP, Dr. Gregg Stone, a leader in the field of interventional cardiology trials, begins by discussing the adverse consequences of bleeding in general and the potential advantages of the direct thrombin inhibitor bivalirudin. He then describes the results of past trials of bivalirudin in ACS and PCI, namely REPLACE-2 and ACUITY, and then gives a detailed analysis of the results of HORIZONS-AMI, a trial of bivalirudin monotherapy versus heparin plus GP IIb/IIIa therapy in patients with STEMI undergoing PCI.
Click to Learn More About This Program
|
|
In this regional mega-summit, issues regarding treatment of hypertension are discussed, with a particular emphasis on the role of older and newer generation, cardioselective beta-blockers (BBs). In this Expert Perspective, key issues, trials, and analysis presented by 3 national experts in hypertension and preventive cardiology are summarized.
Click to Learn More About This Program |
|
In this excellent program, experts on acute coronary syndromes (ACS) and percutaneous coronary interventions (PCIs) discuss important issues related to the pharmacological treatment of patients with ACS, particularly those who are treated with PCI. The panel consists mostly of European experts, who are joined by one American authority.
Click to Learn More About This Program |
|
In this highly educational program, three leading experts in cardiovascular anesthesiology discuss important issues related to acute blood pressure (BP) management during anesthesia, with particular emphasis on cardiovascular anesthesia. Issues related to tight and accurate control of BP are discussed.
Click to Learn More About This Program |
|
In this highly informative program, national and international experts on acute coronary syndromes and percutaneous coronary interventions discuss important issues related to the pharmacological treatment of patients with acute coronary syndromes, particularly those who are treated with percutaneous coronary intervention.
Click to Learn More About This Program |
|
In this extremely practical and educational WebCAST, national and international experts on hypertension—and the renin-angiotensin-aldosterone system (RAAS), in particular—discuss advances in our understanding of hypertension and how inhibition of the RAAS system can be used to treat hypertension as well as heart failure.
Click to Learn More About This Program |
|
In this evidence-based, practice-focused edition of STEMI-WRAP, Dr Charles V. Pollack discusses the epidemiology and pathophysiology of STEMI, ACC/AHA guidelines for STEMI treatment, general principles for ED STEMI management, new trials focused on antiplatelet therapy, and recommendations for antiplatelet and antithrombin therapy in patients with STEMI.
Click to Learn More About This Program
|
|
 |
|
 |
|
  |
|
  |
|
  |
|
  |
|
|
|
Click Here for
Expert-Generated and Evidence-Based Reviews
of Important Developments in Clinical Medicine—New
Updates in
Hepatitis, MRSA, and Postoperative Ileus |
|
|
| |
|
| |
|
|
